Sumitomo Pharma Co., Ltd. (DNPUF)

Sumitomo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,779	1,934	1,045	2,421	3,952	6,922
Market Cap Growth	85.01%	85.01%	-56.82%	-38.75%	-42.91%	33.63%
Enterprise Value	4,752	3,864	3,527	2,604	4,995	8,376
Last Close Price	6.34	4.76	2.40	6.38	10.22	18.75
PE Ratio	17.61	12.26	-	-	8.51	13.62
PS Ratio	1.04	0.73	0.50	0.58	0.86	1.48
PB Ratio	2.46	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	52.01	36.19	-	92.74	20.09	5.91
P/OCF Ratio	25.22	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	1.76	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	18.61	15.00	-	-	6.17	12.04
EV/EBIT Ratio	57.86	44.43	-	-	10.12	17.06
EV/FCF Ratio	88.94	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	1.85	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	8.14	8.14	-	-	2.89	3.78
Debt / FCF Ratio	39.27	39.27	-	99.82	11.91	2.24
Asset Turnover	0.48	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.46	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.43	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.07	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	14.52%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	0.99%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Capital (ROIC)	1.52%	1.52%	-33.20%	-9.23%	3.95%	3.60%
Return on Capital Employed (ROCE)	2.60%	2.60%	-	-	5.80%	5.30%
Earnings Yield	5.68%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	1.92%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.48%	2.26%	1.35%
Payout Ratio	0.01%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.48%	2.26%	1.35%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.